Posiphen reduced APP and/or Aβ42 levels in the cerebral cortex of wild-type mice [2] and transgenic mice over-expressing the human APP gene with the Swedish mutation K670N/M671L (APPSWE), a model of early-onset AD [7]. Here, APP is linked to Alzheimer disease.